フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Avanti Communications Group Plc 21 December 2009 ? Date: 21 December 2009 On behalf of: Avanti Communications Group plc ("Avanti", "the Group...
NEW YORK, Aug. 29 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Merrill Lynch's 12% Callable STRIDES Linked...
IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN BOARD: CLSC) , a pharmaceutical development company...
The previously announced one-for-four reverse split by AVANIR Pharmaceuticals (AMEX:AVN) of its common stock has become effective, with post-split...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that it has signed an exclusive agreement with a leading importer and distributor of...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that Randall E. Kaye, M.D. has joined the company in the newly created role of Vice President of...
AVANIR Pharmaceuticals (AMEX: AVN) announced today that its Board of Directors has approved the implementation of a one-for-four reverse split of...
AVANIR Pharmaceuticals (AMEX:AVN) will be presenting at the 24th Annual JPMorgan Healthcare Conference on Wednesday, January 11, 2005, at 4:00...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that a Phase I study has been initiated in partnership with AstraZeneca UK Limited (AstraZeneca...
AVANIR Pharmaceuticals (AMEX: AVN) announced today that its presentation at the Lazard Capital Markets Annual Life Sciences Conference in New...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that Scott M. Whitcup, M.D., has been elected to the company's board of directors to fill a...
AVANIR Pharmaceuticals (AMEX: AVN) will be presenting at CIBC World Markets 16th Annual Healthcare Conference on Tuesday, November 8, 2005, at...
AVANIR Pharmaceuticals (AMEX: AVN) today announced it has obtained commitments to purchase $16.15 million of its common stock in a...
AVANIR Pharmaceuticals (AMEX:AVN) announced today that Craig A. Wheeler has been elected to the company's Board of Directors to fill a vacancy...
AVANIR Pharmaceuticals (AMEX:AVN) announced that during discussion with the U.S. Food and Drug Administration (FDA) yesterday regarding AVANIR's...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す